Key Insights

Highlights

Success Rate

76% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.4%

5 terminated out of 44 trials

Success Rate

76.2%

-10.3% vs benchmark

Late-Stage Pipeline

7%

3 trials in Phase 3/4

Results Transparency

25%

4 of 16 completed with results

Key Signals

4 with results76% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (15)
P 1 (3)
P 2 (5)
P 3 (2)
P 4 (1)

Trial Status

Completed16
Unknown10
Recruiting6
Terminated5
Active Not Recruiting3
Withdrawn2

Trial Success Rate

76.2%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT07527715RecruitingPrimary

Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy

NCT07491237Not Yet Recruiting

RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases

NCT04359238Not ApplicableCompletedPrimary

activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch

NCT03340675Phase 2Completed

Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy

NCT05524077Not ApplicableActive Not Recruiting

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia

NCT06546137Recruiting

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

NCT05981092Active Not RecruitingPrimary

A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM)

NCT03533517Not ApplicableActive Not Recruiting

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

NCT05321875Phase 3RecruitingPrimary

Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)

NCT06091475Not ApplicableRecruiting

Therapy to Maintain Remission in Dilated Cardiomyopathy

NCT03560167Not ApplicableCompleted

Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation

NCT02445534RecruitingPrimary

Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy

NCT04225520Not ApplicableRecruiting

AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT

NCT06039072UnknownPrimary

Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function

NCT04192214Phase 2CompletedPrimary

The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor

NCT03779646Phase 2Unknown

Bisoprolol in DMD Early Cardiomyopathy

NCT02717143Completed

French National Observatory Tracking Viral Myocarditis: Mortality, Cardiovascular Events, Sequels on (Magnetic Resonance Imaging) MRI

NCT04475315Not ApplicableWithdrawn

Ventricular Sling for Heart Failure With Reduced Ejection Fraction

NCT02352129Not ApplicableCompletedPrimary

Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy

NCT01260402Not ApplicableCompleted

Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.

Scroll to load more

Research Network

Activity Timeline